Back to today’s briefing

Story perspectives

Canada's Cervical Cancer Rates Stall Amid HPV Vaccine Decline

11/18/2025

22 2 Full Breakdown

Summary

Story summary

Cervical cancer rates in Canada have plateaued, with the annual change nearly zero from 2005 to 2021.
The Canadian Cancer Society attributes the stagnation to lower HPV vaccination rates and reduced screening.
Researchers at Chiba University are developing an intranasal therapeutic vaccine for existing HPV infections.
The vaccine could offer a non-invasive option, enhance local immune responses, and improve quality of life.

1 of 1

Story summary

Cervical cancer rates in Canada have plateaued, with the annual change nearly zero from 2005 to 2021.
The Canadian Cancer Society attributes the stagnation to lower HPV vaccination rates and reduced screening.
Researchers at Chiba University are developing an intranasal therapeutic vaccine for existing HPV infections.
The vaccine could offer a non-invasive option, enhance local immune responses, and improve quality of life.